Acquired factor VIII inhibitor associated with chronic interferon‐alpha therapy in a patient with haemophilia A
- 1 June 1994
- journal article
- case report
- Published by Wiley in British Journal of Haematology
- Vol. 87 (2) , 434-436
- https://doi.org/10.1111/j.1365-2141.1994.tb04941.x
Abstract
Both the development of factor VIII inhibitors and infection by hepatitis C virus are serious complications of haemophilia A. We describe the first reported case of the subsequent development of a factor VIII inhibitor in a patient with haemophilia A after treatment with interferon-alpha for chronic active hepatitis C.Keywords
This publication has 9 references indexed in Scilit:
- Lupus-like autoimmune disease induced by interferon therapy for myeloproliferative disordersClinical Immunology and Immunopathology, 1992
- Rheumatoid Arthritis-like Disease after Alpha-Interferon TherapyAnnals of Internal Medicine, 1992
- Incidence of development of factor VIII and factor IX inhibitors in haemophiliacsThe Lancet, 1992
- A randomized controlled trial of recombinant interferon-alpha in chronic hepatitis C in hemophiliacsBlood, 1991
- Autoimmunity after Alpha-Interferon Therapy for Malignant Carcinoid TumorsAnnals of Internal Medicine, 1991
- Treatment of Chronic Hepatitis C with Recombinant Interferon AlfaNew England Journal of Medicine, 1989
- Induction of Immune Tolerance in Patients with Hemophilia and Antibodies to Factor VIII by Combined Treatment with Intravenous IgG, Cyclophosphamide, and Factor VIIINew England Journal of Medicine, 1988
- Alpha-Interferon and Immune Hemolytic AnemiaAnnals of Internal Medicine, 1986
- Auto‐immune thrombocytopenia related to interferon therapyScandinavian Journal of Haematology, 1986